128 related articles for article (PubMed ID: 2164620)
1. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
[TBL] [Abstract][Full Text] [Related]
2. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
[TBL] [Abstract][Full Text] [Related]
3. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
4. The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.
Jockenhövel F; Lederbogen S; Olbricht T; Schmidt-Gayk H; Krenning EP; Lamberts SW; Reinwein D
Clin Investig; 1994 Jan; 72(2):127-33. PubMed ID: 8186658
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
[TBL] [Abstract][Full Text] [Related]
7. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
8. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
9. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
White A; Tan K; Gray C; Roberts I; Ratcliffe JG
Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
[TBL] [Abstract][Full Text] [Related]
10. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
11. Vipoma, glucagonoma and the role of Sandostatin.
Bloom SR
NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
[No Abstract] [Full Text] [Related]
12. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
13. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
[TBL] [Abstract][Full Text] [Related]
15. Silent human pancreatic glucagonoma and "A" nesidioblastosis.
Balas D; Senegas-Balas F; Delvaux M; Bertrand C; Fagot-Revurat P; Rumeau JL; Ribet A
Pancreas; 1988; 3(6):734-9. PubMed ID: 2851784
[TBL] [Abstract][Full Text] [Related]
16. Response of glucagonoma syndrome to lomustine.
Khandekar JD; Sriratana P
Cancer Treat Rep; 1986 Mar; 70(3):433-4. PubMed ID: 3006914
[No Abstract] [Full Text] [Related]
17. Successful treatment of metastatic glucagonoma with dacarbazine.
Kurose T; Seino Y; Ishida H; Fujita J; Taminato T; Matsukura M; Imura H
Lancet; 1984 Mar; 1(8377):621-2. PubMed ID: 6142319
[No Abstract] [Full Text] [Related]
18. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
19. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
20. Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma.
Holmes A; Kilpatrick C; Proietto J; Green MD
Am J Med; 1991 Oct; 91(4):434-6. PubMed ID: 1951389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
